This is the authors' abstract. We don't add key points for this paper.
Translational Virology in PregnancyViral pandemics, like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are becoming more common and disproportionately impact the health of pregnant individuals and their fetuses.Recently, the probability of an extreme epidemic similar in intensity to the 1918 "Spanish influenza" with roughly 32 million deaths was estimated at 1.9% annually (1).For an individual born in 2000, this estimate translates to a 38% lifetime probability of experiencing an extreme epidemic by 2020.This probability estimate was expected to increase up to three-fold due to human-environment interactions, disease emergence from zoonotic reservoirs, and climate change (1).Depending on the virus, an infection during pregnancy may impart risk for more severe maternal disease, preterm birth, preeclampsia, stillbirth, fetal congenital anomalies and/or a longterm risk for neuropsychiatric disease in the children (2-9).This Research Topic includes scientific manuscripts broadly covering viral infections in pregnancy and their impact on pregnancy outcome and the maternal-placental-fetal immune response.Here, we summarize the articles included in this Research Topic and their importance to the field of translational virology in pregnancy.Understanding the impact of viral infections in pregnancy on the fetus typically begins with in vitro and in vivo models with a focus on the placental response to infection.Sheridan et al. reviewed the wide range of current human placental models that include primary trophoblast cell and explant cultures, trophoblast cell lines, and trophoblast stem cells and organoids.This review also discusses how these models may be used to learn about viral trafficking and placental immune defense as well as their strengths and limitations.Since viral infection of the placenta is thought to play a pivotal role in adverse pregnancy outcomes, an important research area is the investigation of placental immunopathology and factors permitting or restricting viral replication at the maternal-fetal interface.Devi Negi et al. explored the role of interleukin-10 (IL-10) in viral clearance from uterine and placental tissues in a murine model of lymphocytic choriomeningitis virus (Armstrong; LCMV-Arm).High IL-10 at the maternal-fetal interface impaired viral clearance suggesting that modulation of IL-10 expression may be beneficial in preventing adverse pregnancy outcomes.In a study of human placentas from women testing positive for COVID-19, Sharps et al. evaluated the distribution of immune cells and found a significant increase in the number of CD163 + placental macrophages (Hofbauer cells) and vascularity in the COVID-19 group.The assortment of available in vitro and in vivo systems for modeling placental viral infections are essential for understanding the role of immune responses in controlling viruses at the maternal-fetal interface.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Waldorf et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: